Molecular Scores to Predict Ovarian Cancer Outcomes: A Worthy Goal, but Not Ready for Prime Time

Por Swisher, Elizabeth M., Taniguchi, Toshiyasu, Karlan, Beth Y.
Publicado em 2012

Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System

Por Wiedemeyer, W. Ruprecht, Beach, Jessica A., Karlan, Beth Y.
Publicado em 2014

A Web-based Information System Supporting Gynecologic Oncology Translational Research

Por Baldwin, Rae Lynn, Dulbandzhyan, Ronda, Karlan, Beth Y., Duncan, Raymond G.
Publicado em 2001

Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers

Por Li, Andrew J., Elmore, R. Geoffrey, Chen, Ida Yii-der, Karlan, Beth Y.
Publicado no Gynecol Oncol (2009)

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

Por Swisher, Elizabeth M., Sakai, Wataru, Karlan, Beth Y., Wurz, Kaitlyn, Urban, Nicole, Taniguchi, Toshiyasu
Publicado em 2008

Lynch Syndrome among Gynecologic Oncology Patients Meeting Bethesda Guidelines for Screening

Por Walsh, Christine S., Blum, Audra, Walts, Ann, Alsabeh, Randa, Tran, Hang, Koeffler, H. Phillip, Karlan, Beth Y.
Publicado em 2010

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation

Por Liu, Zhenqiu, Beach, Jessica A., Agadjanian, Hasmik, Jia, Dongyu, Aspuria, Paul-Joseph, Karlan, Beth Y., Orsulic, Sandra
Publicado no Gynecol Oncol (2015)

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells

Por Qu, Ying, Han, Bingchen, Yu, Yi, Yao, Weiwu, Bose, Shikha, Karlan, Beth Y., Giuliano, Armando E., Cui, Xiaojiang
Publicado no PLoS One (2015)

Salpingectomy as a Means to Reduce Ovarian Cancer Risk

Por Daly, Mary B., Dresher, Charles W., Yates, Melinda S., Jeter, Joanne M., Karlan, Beth Y., Alberts, David S., Lu, Karen H.
Publicado no Cancer Prev Res (Phila) (2015)

Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma

Por Novak, Marián, Lester, Jenny, Karst, Alison M., Parkash, Vinita, Hirsch, Michelle S., Crum, Christopher P., Karlan, Beth Y., Drapkin, Ronny
Publicado no Gynecol Oncol (2015)

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Por Konstantinopoulos, Panagiotis A., Spentzos, Dimitrios, Karlan, Beth Y., Taniguchi, Toshiyasu, Fountzilas, Elena, Francoeur, Nancy, Levine, Douglas A., Cannistra, Stephen A.
Publicado em 2010

Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas

Por Walsh, Christine S., Ogawa, Seishi, Scoles, Daniel R., Miller, Carl W., Kawamata, Norihiko, Narod, Steven A., Koeffler, H. Phillip, Karlan, Beth Y.
Publicado em 2008

Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection

Por Schummer, Michèl, Green, Ann, Beatty, J. David, Karlan, Beth Y., Karlan, Scott, Gross, Jenny, Thornton, Sean, McIntosh, Martin, Urban, Nicole
Publicado em 2010

Correction: Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection

Por Schummer, Michèl, Green, Ann, Beatty, J. David, Karlan, Beth Y., Karlan, Scott, Gross, Jenny, Thornton, Sean, McIntosh, Martin, Urban, Nicole
Publicado em 2010

BRCA1 Germline Mutations May Be Associated With Reduced Ovarian Reserve

Por Wang, Erica T., Pisarska, Margareta D., Bresee, Catherine, da Chen, Yii-Der I, Lester, Jenny, Afshar, Yalda, Alexander, Carolyn, Karlan, Beth Y.
Publicado no Fertil Steril (2014)

Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer

Por Beach, Jessica A., Aspuria, Paul-Joseph P., Cheon, Dong-Joo, Lawrenson, Kate, Agadjanian, Hasmik, Walsh, Christine S., Karlan, Beth Y., Orsulic, Sandra
Publicado no Oncotarget (2015)

FOXC2 augments tumor propagation and metastasis in osteosarcoma

Por Gozo, Maricel C., Jia, Dongyu, Aspuria, Paul-Joseph, Cheon, Dong-Joo, Miura, Naoyuki, Walts, Ann E., Karlan, Beth Y., Orsulic, Sandra
Publicado no Oncotarget (2016)

Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas

Por Norquist, Barbara, Wurz, Kaitlyn A., Pennil, Christopher C., Garcia, Rochelle, Gross, Jenny, Sakai, Wataru, Karlan, Beth Y., Taniguchi, Toshiyasu, Swisher, Elizabeth M.
Publicado em 2011

Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer

Por Urban, Nicole, Thorpe, Jason, Karlan, Beth Y., McIntosh, Martin W., Palomares, Melanie R., Daly, Mary B., Paley, Pamela, Drescher, Charles W.
Publicado em 2012

BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma

Por Ibrahim, Nageatte, He, Lei, Leong, Chee-Onn, Xing, Deyin, Karlan, Beth Y., Swisher, Elizabeth M., Rueda, Bo R., Orsulic, Sandra, Ellisen, Leif W.
Publicado em 2010